OBJECTIVES: To investigate the extent to which pharmacoepidemiologic groupings are homogeneous in terms of clinical properties. METHODS: In our analysis, we classified drug subgroups from the pharmacoepidemiologic Anatomical Therapeutic Chemical (ATC) classification system based on clinical drug properties. We established mappings from ATC fifth level drug entities to drug property annotations in the National Drug File Reference Terminology (NDF-RT), including therapeutic categories, mechanisms of action, and physiologic effects. Based on the annotations for the individual drugs we computed homogeneity scores for all ATC groups and analyzed their distribution. CONCLUSIONS: We found ATC groups to be generally homogeneous, more so for mechanisms of action, and physiologic effects than for therapeutic intent. However, only half of all ATC drugs can be analyzed with this approach, in part because of missing properties in NDF-RT.
OBJECTIVES: To investigate the extent to which pharmacoepidemiologic groupings are homogeneous in terms of clinical properties. METHODS: In our analysis, we classified drug subgroups from the pharmacoepidemiologic Anatomical Therapeutic Chemical (ATC) classification system based on clinical drug properties. We established mappings from ATC fifth level drug entities to drug property annotations in the National Drug File Reference Terminology (NDF-RT), including therapeutic categories, mechanisms of action, and physiologic effects. Based on the annotations for the individual drugs we computed homogeneity scores for all ATC groups and analyzed their distribution. CONCLUSIONS: We found ATC groups to be generally homogeneous, more so for mechanisms of action, and physiologic effects than for therapeutic intent. However, only half of all ATC drugs can be analyzed with this approach, in part because of missing properties in NDF-RT.
Authors: Michael J Lincoln; Steven H Brown; Viet Nguyen; Tim Cromwell; John Carter; Mark Erlbaum; Mark Tuttle Journal: Stud Health Technol Inform Date: 2004
Authors: Jyotishman Pathak; Sean P Murphy; Brian N Willaert; Hilal M Kremers; Barbara P Yawn; Walter A Rocca; Christopher G Chute Journal: AMIA Annu Symp Proc Date: 2011-10-22
Authors: Paul Avillach; Jean-Charles Dufour; Gayo Diallo; Francesco Salvo; Michel Joubert; Frantz Thiessard; Fleur Mougin; Gianluca Trifirò; Annie Fourrier-Réglat; Antoine Pariente; Marius Fieschi Journal: J Am Med Inform Assoc Date: 2012-11-29 Impact factor: 4.497
Authors: Antje Neubert; Yingfen Hsia; Lolkje T W de Jong-van den Berg; Katrin Janhsen; Gerd Glaeske; Kari Furu; Helle Kieler; Mette Nørgaard; Antonio Clavenna; Ian C K Wong Journal: Br J Clin Pharmacol Date: 2011-12 Impact factor: 4.335
Authors: Sieta T de Vries; Petra Denig; Corine Ekhart; Jako S Burgers; Nanno Kleefstra; Peter G M Mol; Eugène P van Puijenbroek Journal: Br J Clin Pharmacol Date: 2019-04-29 Impact factor: 4.335